Tranceformation: Enhancing Control of Mind, Brain, Body and App-Based Dissemination

David Spiegel

Presented by

Dr David Spiegel

Post-Convention
Full Day Workshop

Monday
14th November

Price: £225.00
Early Bird Price!

Hypnosis was the first concept of psychotherapy introduced into Western medicine and psychology. While it has been shown to be safe and effective for more than two centuries, hypnosis is an under-appreciated means of enhancing control of consciousness with enormous therapeutic potential.

We will examine the nature of hypnosis, its efficacy, and brain mechanisms underlying it. We will discuss the clinical utility of measuring hypnotizability, and demonstrate the use of the Hypnotic Induction Profile, a brief and reliable clinical measurement that facilitates initiation of hypnosis and provides useful clinical information.

The uses of hypnosis for problems such as stress management, enhancing focus, improving sleep, controlling pain, stopping smoking and vaping, treating phobias, eating well, dealing with grief and loss, and treating traumatic stress will be discussed and demonstrated.

Novel means of dissemination involving interactive hypnosis apps that are making safe and effective hypnosis skill training widely available will be presented.

Introducing

Dr David Spiegel

Dr. David Spiegel is Willson Professor and Associate Chair of Psychiatry & Behavioral Sciences and Medical Director of the Center for Integrative Medicine at Stanford University School of Medicine, where he has been a member of the academic faculty since 1975. Dr. Spiegel has more than 40 years of clinical and research experience studying psycho-oncology, stress and health, pain control, psychoneuroendocrinology, sleep, hypnosis, and conducting randomized clinical trials involving psychotherapy for cancer patients. He has published thirteen books, 404 scientific journal articles, and 170 book chapters on hypnosis, psychosocial oncology, stress physiology, trauma, and psychotherapy. His research has been supported by the National Institute of Mental Health, the National Cancer Institute, the National Institute on Aging, the National Center for Complementary and Integrative Health, the John D. and Catherine T. MacArthur Foundation, the Fetzer Institute, the Dana Foundation for Brain Sciences, and the Nathan S. Cummings Foundation. He was a member of the work groups on stressor and trauma-related disorders for the DSM-IV and DSM-5 editions of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders.